311 related articles for article (PubMed ID: 20679220)
1. Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development.
Ueda T; Sasaki M; Elia AJ; Chio II; Hamada K; Fukunaga R; Mak TW
Proc Natl Acad Sci U S A; 2010 Aug; 107(32):13984-90. PubMed ID: 20679220
[TBL] [Abstract][Full Text] [Related]
2. Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development.
Ueda T; Watanabe-Fukunaga R; Fukuyama H; Nagata S; Fukunaga R
Mol Cell Biol; 2004 Aug; 24(15):6539-49. PubMed ID: 15254222
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2.
Waskiewicz AJ; Flynn A; Proud CG; Cooper JA
EMBO J; 1997 Apr; 16(8):1909-20. PubMed ID: 9155017
[TBL] [Abstract][Full Text] [Related]
4. Regulation of eukaryotic initiation factor 4E (eIF4E) phosphorylation by mitogen-activated protein kinase occurs through modulation of Mnk1-eIF4G interaction.
Shveygert M; Kaiser C; Bradrick SS; Gromeier M
Mol Cell Biol; 2010 Nov; 30(21):5160-7. PubMed ID: 20823271
[TBL] [Abstract][Full Text] [Related]
5. MNK1 pathway activity maintains protein synthesis in rapalog-treated gliomas.
Grzmil M; Huber RM; Hess D; Frank S; Hynx D; Moncayo G; Klein D; Merlo A; Hemmings BA
J Clin Invest; 2014 Feb; 124(2):742-54. PubMed ID: 24401275
[TBL] [Abstract][Full Text] [Related]
6. Roles of mitogen-activated protein kinase signal-integrating kinases 1 and 2 in oxidant-mediated eIF4E phosphorylation.
Shenberger JS; Zhang L; Hughlock MK; Ueda T; Watanabe-Fukunaga R; Fukunaga R
Int J Biochem Cell Biol; 2007; 39(10):1828-42. PubMed ID: 17689282
[TBL] [Abstract][Full Text] [Related]
7. Mnk1 and 2 are dispensable for T cell development and activation but important for the pathogenesis of experimental autoimmune encephalomyelitis.
Gorentla BK; Krishna S; Shin J; Inoue M; Shinohara ML; Grayson JM; Fukunaga R; Zhong XP
J Immunol; 2013 Feb; 190(3):1026-37. PubMed ID: 23269249
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation.
Wang X; Yue P; Chan CB; Ye K; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Fu H; Khuri FR; Sun SY
Mol Cell Biol; 2007 Nov; 27(21):7405-13. PubMed ID: 17724079
[TBL] [Abstract][Full Text] [Related]
9. Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2.
Knauf U; Tschopp C; Gram H
Mol Cell Biol; 2001 Aug; 21(16):5500-11. PubMed ID: 11463832
[TBL] [Abstract][Full Text] [Related]
10. The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer.
D'Abronzo LS; Bose S; Crapuchettes ME; Beggs RE; Vinall RL; Tepper CG; Siddiqui S; Mudryj M; Melgoza FU; Durbin-Johnson BP; deVere White RW; Ghosh PM
Oncogene; 2017 Nov; 36(46):6359-6373. PubMed ID: 28745319
[TBL] [Abstract][Full Text] [Related]
11. The MAP kinase-interacting kinases regulate cell migration, vimentin expression and eIF4E/CYFIP1 binding.
Beggs JE; Tian S; Jones GG; Xie J; Iadevaia V; Jenei V; Thomas G; Proud CG
Biochem J; 2015 Apr; 467(1):63-76. PubMed ID: 25588502
[TBL] [Abstract][Full Text] [Related]
12. Type I interferon (IFN)-dependent activation of Mnk1 and its role in the generation of growth inhibitory responses.
Joshi S; Kaur S; Redig AJ; Goldsborough K; David K; Ueda T; Watanabe-Fukunaga R; Baker DP; Fish EN; Fukunaga R; Platanias LC
Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12097-102. PubMed ID: 19574459
[TBL] [Abstract][Full Text] [Related]
13. Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK Inhibitors.
Dreas A; Mikulski M; Milik M; Fabritius CH; Brzózka K; Rzymski T
Curr Med Chem; 2017; 24(28):3025-3053. PubMed ID: 28164761
[TBL] [Abstract][Full Text] [Related]
14. The mitogen-activated protein kinase signal-integrating kinase Mnk2 is a eukaryotic initiation factor 4E kinase with high levels of basal activity in mammalian cells.
Scheper GC; Morrice NA; Kleijn M; Proud CG
Mol Cell Biol; 2001 Feb; 21(3):743-54. PubMed ID: 11154262
[TBL] [Abstract][Full Text] [Related]
15. MNK1 and MNK2 Expression in the Human Dorsal Root and Trigeminal Ganglion.
Shiers S; Sahn JJ; Price TJ
Neuroscience; 2023 Apr; 515():96-107. PubMed ID: 36764601
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Mitogen-activated Protein Kinase (MAPK)-interacting Kinase (MNK) Preferentially Affects Translation of mRNAs Containing Both a 5'-Terminal Cap and Hairpin.
Korneeva NL; Song A; Gram H; Edens MA; Rhoads RE
J Biol Chem; 2016 Feb; 291(7):3455-67. PubMed ID: 26668315
[TBL] [Abstract][Full Text] [Related]
17. Mnk1 is required for angiotensin II-induced protein synthesis in vascular smooth muscle cells.
Ishida M; Ishida T; Nakashima H; Miho N; Miyagawa K; Chayama K; Oshima T; Kambe M; Yoshizumi M
Circ Res; 2003 Dec; 93(12):1218-24. PubMed ID: 14605021
[TBL] [Abstract][Full Text] [Related]
18. Diet-dependent effects of the Drosophila Mnk1/Mnk2 homolog Lk6 on growth via eIF4E.
Reiling JH; Doepfner KT; Hafen E; Stocker H
Curr Biol; 2005 Jan; 15(1):24-30. PubMed ID: 15649360
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin enhances eIF4E phosphorylation by activating MAP kinase-interacting kinase 2a (Mnk2a).
Stead RL; Proud CG
FEBS Lett; 2013 Aug; 587(16):2623-8. PubMed ID: 23831578
[TBL] [Abstract][Full Text] [Related]
20. Progress in developing MNK inhibitors.
Jin X; Yu R; Wang X; Proud CG; Jiang T
Eur J Med Chem; 2021 Jul; 219():113420. PubMed ID: 33892273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
